U.S. Study Confirms Effectiveness of Stereotactic Radiotherapy for Early-stage Lung Cancer
March 18, 2010 — Researchers affiliated with a Phase II North American multicenter study have reported that sterotactic radiotherapy for Stage TI-II non–small cell lung cancer (NSCLC) results in a three-year survival rate of 56% in medically inoperable patients. The details of this study were published in the March 17, 2010 issue of the Journal of the American Medical Association.
Combined Modality Therapy Preserves Bladder and Offers Long-term Survival in Invasive Bladder Cancer
March 18, 2010 — Combined modality therapy (CMT) preserves the bladder, achieves complete response (CR), and offers long-term survival in approximately 70% of patients with invasive bladder cancer, according to the results of a 15-year study presented at 2010 American Society of Clinical Oncology Genitourinary Symposium March 5-7 in San Francisco.
Low-income Women Experience Delayed Follow-up of Abnormal Mammograms
March 18, 2010 — Researchers affiliated with Harvard University and the National Breast and Cervical Cancer Early Detection Program (BCCEDP) have reported that there is a significant delay in follow-up diagnostic tests and treatment following a positive mammogram in one-third of low-income women participating in this program. The details of this study were published early online in the Archives of Internal Medicine on March 16, 2010.
Select news items provided by Reuters Health